A bill to cap the cost of a life-saving drug used to treat diabetes passed the Illinois Senate this week with the help of local lawmakers.
The legislation, S.B. 667, caps the out-of-pocket cost for patients to $100 for a 30-day supply of insulin. It passed with bipartisan support, according to a news release.
“Families across Will and Kendall counties should not have to choose between basic necessities and paying for life-saving prescription drugs,” State Sen. Jennifer Bertino-Tarrant said in the release. “It is time for the state to intervene to ensure greedy corporations are not placing profits before people.”
Bertino-Tarrant, D-Shorewood, was a chief co-sponsor of the bill. State Sen. Michael Hastings, D-Tinley Park, was also among the 48 senators who voted in favor of the measure.
“Many families have been left to make an impossible choice: Doses of the medicine they need to survive on a daily basis, or their most basic necessities,” Hastings said in a news release. “That is no choice at all. I urge the House to pass this legislation and make this medication affordable.”
According to the American Diabetes Association, there are over 30 million Americans who have diabetes, 7.4 million of whom require insulin every day to survive.
The legislation has also garnered the support of several advocacy organizations, including the American Diabetes Association, Illinois Alliance for Retired Americans, Illinois State Medical Society, Illinois Pharmacists Association and AARP.
State Sens. Pat McGuire, D-Joliet, and Sue Rezin, R-Morris, also voted for the legislation. The bill now heads to the House of Representatives.